Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver  by Gebel, Thomas et al.
'Volume 309, number 1, 37-40 FEBS 11471 
O 1992 Fcdcr=tlon of European Biochemk~i So¢ieti= 0014~79~9~$5,00 
Au~t=t !~92 
Induction of the peroxisom¢ proliferator activated receptor by fenofibrate 
in rat liver 
Thomas  Gcbcl ,  Michael Arand and Franz O~sch 
lns¢i~ut¢ of Toxtcolo&y, Univers/t), of Mah~:, Ober# Zahlbacherstr. 67. W 6500 Main:, Germany 
Received 6 July 1992 
The procc.u of pcroxisome prollfcration i rodent liver by hypolipidemic compounds and related subst~nc~-s luzs re=early ~ shown to I~ 
r~r,~ptor-medlated, In the pr~¢nt study, vvc here examined the eliot of oral administration of the stronll l~roximme proliferator fcazofibraze on 
the hepatic ¢xpreuion I~vel o1" the pe.roxisome proliferator activated receptor (PPAR) in rats. [mmunoblots of rat liver ¢ytosoh and ucle.at cat ract.s 
usinB antibodies raised allaimt recombinant PPAPJ#.~alaetosid~ fusion proteins revealed a pronounced irmrr, a~ in the zu'nouat ofPPAR protr.hz 
in re~[~n~ tofenofibrate reatment. This induction could also ~ confirmed atthe level of RNA by Northern blottinB. A timc.c,~ut~ inv~ti~lion 
~owed adelayed accumulation f mRNA in rcspon~ to he tr~tmcnt, .taninB on day 2 after a lat~nw p~riod of atI~t one day. Tht~, indt~tion 
of the PPAR as a rcspon.~ to p~rozisom¢ proliferators rep ~r,¢nts one important dimonsion f the pleiotropic effects of p~roxisome proLif~ratora. 
PPAR; Fusion protein; Antibody; mRNA; Hypolipidemic ompound 
I. INTRODUCTION 
Peroxisome proliferation is a pro~ss frequently ob- 
served in the livers of rats and mice in r~pons~ to the 
administration of a specific class of non-genotoxio car- 
cinogcns, the so-called peroxisom¢ proliferators (¢.8. 
fibrat~ such as clofibrate, phthalates such as diethyl- 
h~xylphthalate, tiadenol) ill. After oral administration. 
thes~ substan~s evoke a pleiotropic response in the 
main target organ liver, including an lactose of the 
number and size of peroxisomes, induction of per- 
ozisomal and non.peroxisomal enzymes, liver hypertro- 
phy and hyperplasia, and, as a ions-term effect, hepa- 
tocarcinogenesis [2-5], Bew.ausc of the structural diwr- 
sity of the different I:mroxisome proliferators, the exis. 
ten~ of a Sl~¢ifi¢ te~ptor mediatin$ their effects was 
a matter ofcontrowrsy for several years [6-8]. In 1990, 
the cloning of a sen= belonging to the steroid hormone 
receptor family was reported and its expression product 
was proven to ~nhan~ the transcription of respective 
gen~ in response to the, application of pcroxisome pro- 
liferators [9,10]. However, no direct binding of these 
compounds to this new receptor has b~n shown until 
now. With respect to these findings this protein has b~en 
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termed l~roxisom¢ prcliferator activated r~ptor  
(PPAR). Recently, th~ identification of three closely re. 
luted re©tubers of the hormone receptor supcffamily 
tha~ share extensive homology with the mou.~ PPAR 
has been reported for Xenopus laev~s [1 l]. All the thr~ 
new receptors eem to be stimulated in their biolog, i~M 
activity upon addition of  ~roxisome proliferators to 
the test system. 
To further investi~t~ the signal cascade leading to 
the multiple eff~ts in the liver after application of per- 
oxisome proliferators, we d~ided to rais~ antibodies 
against the PPAR in order to obtain a direct sp~ifio 
probe for the receptor. In the present paler, we report 
on the preparation of a PPAR-sI~.cific antis~rtnn and 
its use for the aeration of PPAR protein in different 
preparations of rat livers. In particular, eviden~ for th~ 
induction of the PPAR by f=nofibrat~, a strong per- 
o~isom¢ proliferator, is presented. 
2. MATERIALS  AND METHODS 
2.1. Materials 
Fenofibrate was providgd by Laboratoir~ Foamier (Font~in¢ los 
Dijon, France), Primer oli=onu~l~tid~ were synth~d on a ~ne 
Ar.~mblor Plus (Pharma~ia, Ftciburs, Germany). Taq polymerase 
was obtained from Perkln-Elmer (Otmrlingen. C~rmany). The fiP~t 
st rand ¢DNA synth~is kit,#as purchased from Pl:armacia (Freibur$, 
Germany). The nonradioactive DNA latmling and dct~tion kit. 4- 
nitro blue t trazolium chl0ridc and 5.bromo.4-chloro.3-indolyl-phms- 
phate were obtained from Ik~hringer Ma nheim (Mannh=im, Ger- 
many). Biodyne A and Fluorotrans m~nbran~s, th~ ~nd antibody 
and the blue marker wcr~ from Pall (Drcieieh, Germany), Sigma 
(De;~nhofen, Germany) and Blorad (MQnchen. Germany), t~p~.- 
tiv¢iy, 
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2,2, Gcm.tmiu~e of PPA /~..~#¢r~/h" tmti.~rr. 
Total RNA was Isohtted from pooled livers of adult male BALWc 
and C$?[HJ6N mice a~cordin&t to Chomczynski and Sacchi [12]. and 
PCII [13} (ddrly cycles, I rain 94"C. I rain 4~1"C, 3 rain "/2"C, each) 
was p~rformed alter mRNA selection and reverse transcription, using 
the olilonucleotid~ AACCCGGGACAATGAACCC'['['rc and 
TTCCCGGGCGGAGTGAAGA as PPAR-sl~cili¢ S'.sen~- and Y- 
anti~n~.primer. The RroRl.IKpn[ (FP 1) =rod #.¢liil#.ll (FP 2) re- 
striction fragments of the amplified PPAR eDNA were fund to the 
I.£Z ~n¢ o1" the bacterial expression wctor pEX2 as detailed in Fill. 
I, After t~nsfocmatlon of these construct=; into the .,E'.. roll strain pop 
2136, the eorrcspondinlI.D-Ilalactosidat, eJPPAR I'usion proteins were 
obtained and purified essentially s described [14.15], New Zealand 
white rabbits were immunixed with th¢obtaiacd preparations accord- 
ing to standard proccdgr~ to yield two p~lyclona| antigen, 
2.3, ,.~tmpl¢ prcpttrtttio~e 
For preparation ofcytosols nnd nucle'ar extracts, male ri ls were fed  
a diet containing 0.25~1, (wlw) I~nofibratc for seven days. For prepare. 
lion of RNA, male r;¢ts wcrc led the ~m¢ diet for one to tweh.¢ duy~. 
All animal,= were starved 12 h before sacrifice e>'.¢'¢pt for throe treated 
for one day only, Livers were xcised after cervical dislo~ttion and 
were either frozen immediatel.v in l quid nit rogen to preserve them for 
the isolation of BNA or processed directly to obtain cyto~ls and 
nuclear extracts as follow~: livers were homo~nizcd in three volumes 
of homollenizntion buffer (20 mM TrIs.HCI. p}t "/.4. containing I mM 
EDTA. 2S mM KCI. imM PMSF, In'lM DTTand 10"~ (wv) gl>~.'erol) 
usinl~ l0 strokes era drillin~ Teflon pestle. The obtained hOmOl~Cnatcs 
were centrifuged for $ rain ut l,Og0 x X. Alter resuspcnsion o1" the 
pallets ill homo=eni~tion buffer (three volumes), centrifulpttion was 
repeated to remove remainders of cytosol. The resultin~l sediments 
were resuspcnded in homot~enization buffer (two volumes] ¢ontaininl~ 
0.4 M NaCI, using a glass I:ontoll=nizer. The suspensions were stirred 
gently for 20 rain on ice with ~ nta~netic stir bar followed by tentrif- 
ul~tion at 100.000 x/~ for 1 h. The r~ovcred supernatant~ r~present- 
ing the nuclear e.xtracts ~=re frozen in liquid nitro=an and stored at 
-80"C until use. The 1,000 x,~ supcrnutants of the fiP~t ccmrifu~tion 
were centrifuged at 10,000 x X for IS rain and the r=ulti.= supcrna- 
tunis were eentriK=ltcd at 100,000 x ~t for I It to yield the cyto~lic 
fractions that were pr~rved and stored like the nuclear extracts. 
RNA was prep;~red from the frozen livers as detailed by Chom=zynski 
and Sacchi [2]. 
2.4. A.ol.vlietd procedures 
Protein concentrations were determined aceonlinl~ to Bradford [16], 
Cytosols and nuclear extracts w~rc subjec[ed to SDS-PAGE on 8 m 
25~ gradient Itcls usinl~ the Phast System (Pharm~tcia). Sub~quent 
el¢ctrotran~fer to Fh,orolrans membranes was performed on the ~m¢ 
app;m'tt us accordin B co the mannfiict.rers recommendations for .1 Vh. 
lmmunodetection w;ts carried out by the nlethod ofTowbin et al, [I 7] 
t=sin~ one of the PPAIL.speciflc antis¢ra (1:200) as the first antibody 
and an alkaline phosph;.ase-couplcd second antibody II:i000). 4. 
nitro blue [elrazolium chloride and S.bromo.4-chlo,'o.3.indolyl.phos. 
ph,,t¢ served as chrcmogenic substrates lot' the Iinal visually.alien, 
Total RNAs were run on i% denaturing atlaros¢ gels containing 
formaldehyde and were subsequently transferred to Biodyne A mem- 
branes by standard capillary blotting [IS]. PPAR mRNA was detected 
by hybridi~stion with a digoxii~enin,labelled PPAR.cDNA (S0 nW'ml) 
followed by immunostaining according to the protocol of the kit 
supplier, Prchybridization was carried out at 55"C for4 h in a solution 
containing 10x Denhardt*s (:aqueous olution of Ficoll, polyvinyl- 
pyrrolidone and hovine ~erum albumin. 0,2% each). 2 x SSC (0.3 M 
N:tCI, 30 mM sodium citrate, pH "/.0), 0,_'1% SDS. 0,01 M EDTA and 
100p~lml salmon sperm DNA, After addition of the dcnaLured probe 
hybridization was contlnued overnight under the same conditions, The 
filters were washed In 2 x SSC, 0,~% SDS (2 times. IS rain each) at 
roo=n temperature and 0,1 x SSC, 0.5% SDS (2 times. IS rain each) 
at 55°C and subjected to immunostaining. Color development was 
allowed ovcrnii;ht. 
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Fill. !, Construction or the PPAR.expression vectors. Frallments FP 
I and FP 2 of the PPAR eDNA were ligated into the EroRI/~'=~IH[. 
site located in the 3'.terminal eel;ion of the I~cZ gent of the bacterial 
expression vector OEX2. To yield compatible cads both fm~ent~ 
were first clo.¢d into the plasmid pUC 19, FP l was obtained by 
EcaRYKpI~! digest of the PPAR eDNA and was ~¢t into the EcoR[l 
K#td-sit¢ o[' tile plasnlid. FP 2 was obtained by B£1lIl[tal[ dilr~t of 
[h¢ PPAR eDNA and was liIatcd into the ,~;mI.sit¢ of the phsmid 
after blunt-end generation usinl~ the Klenow frulFnent of DNA polym. 
erase I. Separate restriction diesis of both constructs with EroRI/ 
B.mH[ resulted in {'ra~nents that could be iatcgr;itcd into the EcoR[/ 
#mJaHI.sitc of pEX2 in the correct odcntption and frame to yield 
/~-IlalnetosidaseJPPAR fusion proteins on induction. DBD. putative 
DNA binding domain; LBD, putative li~tnd binding domain, 
3, RESULTS 
The amplification of the PPAR eDNA starting from 
reverse transcribed mRNA of  mouse liver resulted in 
the isolation of the expected 1.4 kb eDNA fragm=nt in 
good yields (2-3 ,u S per ~0/.zl). Tile £coRI/Kpnl.frag. 
m=nt (FP l) and the BgIII/Ba/I.fragment (FP 2) of this 
eDNA were chosen for the expression in bacteria be- 
cause both show low homology to the corresponding 
sequences of other members of tM steroid hormone 
receptor family. After expression as/~-galactosidase fu-
sion proteins and subsequent purification, th~sc prepa- 
rations were used to raise antibodies in rabbits. The 
resulting antiscra both display=d high tilers towards th~ 
fusion proteins. However, only the FP 2-antiserum 
showed specific immunorcactions with rat liver pro- 
teins. Thus. only experiments usin 8 the FP 2-antiserum 
are reported ia the following, Immunoblot analysis of 
hepatic cytosols (Fig. 2) ancl nuclear extracts (data not 
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Fig, 2, Rat liver ¢ytosols (lOng p~r lane) were elcctrol=horesed, blotted 
and immunostained with the FP 2 antiserum as d=rcribe,,d in So.orion 
2. SD, male Spragu=-Dawley rats; F, male Fish r rats; +. fenofibrat¢- 
treated; - .  untreated: M, prcstained molecular weight marker (106 
kDa, 80 RDa. 49.5 kDa. 32.S kDa. 27.5 kDa, 18,5 kDa). The arrow 
marks the position of the PPAR (53 kDa). 
shown) obtained from untreated rats did not show spe- 
cific signals in the expected molecular weight range of 
52-~3 kDa. Instead, two moderately immunoreactive 
proteins with apparent molecular weights of about 33 
and 3ti kDa were detected, 
In contrast, cytosols as well as nuclear extracts pre- 
pared from rats after fenofibrate reatment for one week 
displayed a strongly immunoreactive species with an 
apparent molecalar weight of about 53 kDa. In addi- 
tion, a number of less prominent bands appeared in the 
higher molecular weight range. A typical result ~,,th rat 
cytosol is shown in Fig, 2. 
Northern blot analysis of rat hepatic RNA from ani- 
mals that were treated with fenofibrate for 0-12 days 
indicated a low constitutive xpression of PPAR 
mRNA in rat liver. After a latency period of at least one 
day the level of PPAR mRNA was significantly in- 
creased and the signal remained enhanced for all 12 
days (Fig. 3). Surprisingly, we determined the size of the 
rat PPAR mRNA to be close to 6 kb whereas the size 
of mouse PPAK mRNA was reported to be 1,8 and 2 
kb [91. 
4. DISCUSSION 
Starting from the published cDNA sequence of the 
mouse PPAR [9] we have generated fusion proteins and 
with their aid antisera against defined regions of the 
protein that w0 have designated FP 1 and FP 2. Com- 
parison of the deduced amino acid sequence of mouse 
PPAR to those of the different Xetmpus PPAR-related 
nuclear hormone receptors that have recently been 
cloned [II] revealed a sequence homology of FP  2 
among the mPPAR and the orthologous Xenopus gone 
xPPAR~ of 82% from which an interspecies immuno- 
28S 
1fl5 
0 1 2 37812 
FiB. ;~. Northern blot or li,'er RNA from fenoflbrate.treated rats. Rat 
liver total RNA (10/aS per lane) was elcctrophorcw.d, blotted and 
hyhrid"o.ed with a digoxigeain.lal~lled PPAR eDNA prot¢ as de- 
scribed in $¢~tion 2, The figure below each lane giws the duration of 
the fcnofibrat¢ reatment of the respective rat in days. The arrows 
mark the positions of the ribosomal RNAs. 
logical cross-reaction may reasonably be expected. At 
the same time, the homology to the other members of 
this gene subfamily does not exceed 50%. Therefore, we 
conclude that the 53 kDa protein that strongly interacts 
with our FP 2 antiserum is indeed the rat PPAR. The 
nature of the other, less prominent signals obtained with 
this antiserum is yet unclear. Like the PPAR, most of 
them appear to be feaofibrat¢-treatment dependent and 
we thus speculate that they might repr¢~nt either proc- 
essed variants of the PPAR or other members of a puta- 
tive PPAR-family [I 1]. 
The FP 1 protein sequence homology among mPPAR 
and xPPAR¢ of only 53% suggests a lower degree of 
conservation of the PPAR N-terminus, which could 
serve as an explanation for the failure of our FP l- 
antiserum (anti-mouse PPAR) to det~t the rat PPAR 
protein. 
Our present data clearly indicate the induction of the 
PPAR in rat liver on the level ofmRNA and protein on 
administration f fenofibrate, a strong pcroxisome pro- 
lifcrator, while the constitutive expression appeared to 
be very low. The transcription-stimulating activity of 
the PPAR is significantly enhanced by l:¢roxisome pro- 
liferators as clearly demonstrated by Green and co- 
workers [9,10]. However, they also reported on some 
basal transcriptional ctivity of the PPAR in the ab- 
sence of peroxisome proliferators that was apparently 
dependent on the intracellular concentration f PPAR 
[10]. Since the responsive elements of the differ:nt gen~ 
that are targets for the PPAR may be diiTercntiaily sus- 
ceptible to this receptor in the presence and absence of 
its ligand, the level of receptor expression could repre- 
sent a ,~¢¢ond dimension in the regulation of PPAR- 
dependant gone transcription. 
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